MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Spinal Cord Stem Cell Transplantation is Safe

Back to neurology news Blogs list Cancer blog  


Subscribe To Neurology News RSS Feed  RSS content feed What is RSS feed?

Spinal Cord Stem Cell Transplantation Is Safe

Spinal Cord Stem Cell Transplantation is Safe Hans Keirstead
Transplanting human embryonic stem cells does not cause harm and can be used as a therapeutic strategy for the therapy of acute spinal cord injury, as per a recent study by UC Irvine researchers.

UCI neurobiologist Hans Keirstead and his colleagues at the Reeve-Irvine Research Center observed that rats with either mild or severe spinal cord injuries that were transplanted with a therapy derived from human embryonic stem cells suffered no visible injury or ill effects as a result of the therapy itself. Furthermore, the study confirmed prior findings by Keirstead's lab - since replicated by four other laboratories around the world - that replacing a cell type lost after injury improves the outcome after spinal cord injury in rodents. The findings appear in the current issue of Regenerative Medicine.

"Establishing the safety of implanted embryonic stem cells is crucial before we can move forward with testing these therapys in clinical trials," said Keirstead, an associate professor of anatomy and neurobiology and co-director of UCI's Stem Cell Research Center. "We must always remember that a human clinical trial is an experiment and, going into it, we need to assure ourselves as best as we can that the therapy will not cause harm. This study is an important step in that direction".

In 2005, Keirstead's lab was the first to coax human embryonic stem cells to become highly pure specialized cells known as oligodendrocytes. These cells are the building blocks of myelin, which acts as insulation for nerve fibers and is critical for maintenance of electrical conduction in the central nervous system. When myelin is stripped away through disease or injury, paralysis can occur.

In this study, as in the original one, when the rats suffering from severe spinal cord injury were injected with the oligodendrocytes seven days after injury, the cells migrated to the appropriate sites within the spinal cord and wrapped around the damaged neurons, forming new myelin tissue.

By contrast, the rats who were only mildly impaired showed no increase or decrease in myelin generation, and no change in their walking ability after transplantation. As per Keirstead, the injury was so minor that no loss of myelin occurred. Therefore, a therapy based on remyelination would have no effect and the animals recovered motor function on their own. More importantly, while the therapy did not help with functional recovery, it also did not impair it. Upon further examination, the researchers found no damage to the tissues surrounding the spinal cord indicating that the transplantation had not caused any damage to the animals.

"Our biggest safety concern was that in the case of a severe injury, any harm the stem cell-derived therapy could cause would be masked by the injury itself," Keirstead said. "In this study, we can see in animals that are only slightly injured that the transplantation does not cause visible harm and the injury is not hiding any damage the cells may have caused to the spinal cord or the surrounding tissue".

Keirstead is working with Geron Corp. to bring this therapy for acute spinal cord injury into Phase I clinical trials within the next year.

Frank Cloutier, Monica Siegenthaler and Gabriel Nistor collaborated on the study, which was supported by Geron Corp.; a UC Discovery Grant; the Roman Reed Spinal Cord Injury Research Fund of California; Research for Cure; and individual donations to the Reeve-Irvine Research Center.

UCI is a premier center for stem cell research in California. The university announced last week that it had received a $10 million gift from Bill and Sue Gross in support of stem cell research, including matching funds to construct an $80 million Stem Cell Research Center facility.



Posted by: Daniel    Source




Did you know?
Transplanting human embryonic stem cells does not cause harm and can be used as a therapeutic strategy for the therapy of acute spinal cord injury, as per a recent study by UC Irvine researchers. UCI neurobiologist Hans Keirstead and his colleagues at the Reeve-Irvine Research Center observed that rats with either mild or severe spinal cord injuries that were transplanted with a therapy derived from human embryonic stem cells suffered no visible injury or ill effects as a result of the therapy itself. Furthermore, the study confirmed prior findings by Keirstead's lab - since replicated by four other laboratories around the world - that replacing a cell type lost after injury improves the outcome after spinal cord injury in rodents. The findings appear in the current issue of Regenerative Medicine.

Medicineworld.org: Spinal Cord Stem Cell Transplantation is Safe

Acute bacterial meningitis| Alzheimer's disease| Carpal tunnel syndrome| Cerebral aneurysms| Cerebral palsy| Chronic fatigue syndrome| Cluster headache| Dementia| Epilepsy seizure disorders| Febrile seizures| Guillain barre syndrome| Head injury| Hydrocephalus| Neurology| Insomnia| Low backache| Mental retardation| Migraine headaches| Multiple sclerosis| Myasthenia gravis| Neurological manifestations of aids| Parkinsonism parkinson's disease| Personality disorders| Sleep disorders insomnia| Syncope| Trigeminal neuralgia| Vertigo|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.